The progressive loss of brain network fingerprints in Amyotrophic Lateral Sclerosis predicts clinical impairment

ABSTRACT

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterised by functional connectivity alterations in both motor and extra-motor brain regions. In network analysis, fingerprint represent a valid approach able to assess the subject-specific connectivity features of a given population. Here, we applied the Clinical Connectome Fingerprint (CCF) analysis to source-reconstructed magnetoencephalography (MEG) signals in a cohort of seventy-eight subjects: thirty-nine ALS patients and thirty-nine healthy controls. We set out to develop an identifiability matrix to assess the extent to which each subject was recognisable based on his/her connectome. The analysis was performed in all five canonical frequency bands. Then we built a multilinear regression model to test the ability of “clinical fingerprint” to predict the clinical evolution of disease assessed by the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-r), the King’s disease staging system and the Milano-Torino Staging (MiToS) disease staging system. We found a drop in patients’ identifiability in the alpha band compared to the healthy controls. Furthermore, the “clinical fingerprint” was predictive of ALSFRS-r (p=0.0397; β=32.8), King’s (p=0.0001; β= -7.40) and MiToS (p=0.0025; β= -4.9) scores and negatively correlated with King’s and MiToS scales according to Spearman’s correlation. Our results demonstrated the ability of the CCF approach in assessing the individual motor condition and its relationship with ALS disease. Thanks to the subject-specific characteristic of this approach, we hope that further exploration related to its clinical application may help improve the management of disease.